Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
210,014,211
-
Share change
-
+5,107,339
-
Total reported value
-
$9,105,490,089
-
Put/Call ratio
-
70%
-
Price per share
-
$43.34
-
Number of holders
-
730
-
Value change
-
+$231,559,466
-
Number of buys
-
334
-
Number of sells
-
299
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2016
As of 30 Jun 2016,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
730 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
210,014,211 shares.
The largest 10 holders included
FMR LLC, WELLS FARGO & COMPANY/MN, Fisher Asset Management, LLC, STATE STREET CORP, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, FEDERATED INVESTORS INC /PA/, and BANK OF AMERICA CORP /DE/.
This page lists
730
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.